Insights

Market niche Gnosis specializes in fermentation raw materials and natural finished products for pharmaceutical, nutraceutical, and veterinary applications, presenting a focused entry point for suppliers of GMP-compliant fermentation substrates, specialty enzymes, and bioactive ingredients.

Global network With an international manufacturing network across Europe, the USA, and China and a close tie between R&D and GMP facilities, there is opportunity to pitch scalable supply agreements, cross-border regulatory support, and multi-site manufacturing contracts.

Clinical alignment Active involvement in health claims substantiation and clinical studies suggests partnerships around clinical-grade materials, analytical services, and quality assurance programs to accelerate product development and regulatory approval.

Growth potential Revenues in the low-to-mid millions imply room for expansion through expanded product lines ( Mythocondro and related fermentation-derived materials), contract manufacturing, and ongoing adoption in pharma and animal health markets.

Tech and compliance Existing tech stack and GMP-integrated operations highlight opportunities to offer advanced fermentation technologies, process optimization, and validated supply chain services to enhance quality, traceability, and scale for customers.

Gnosis Tech Stack

Gnosis uses 8 technology products and services including Nameshield, DreamWeaver, Font Awesome, and more. Explore Gnosis's tech stack below.

  • Nameshield
    Domain Name Services
  • DreamWeaver
    Editors
  • Font Awesome
    Font Scripts
  • LinkedIn
    Online Community Software
  • X-XSS-Protection
    Security
  • Bootstrap
    UI Frameworks
  • X-Content-Type-Options
    Web & Portal Technology
  • Apache
    Web Servers

Gnosis's Email Address Formats

Gnosis uses at least 2 format(s):
Gnosis Email FormatsExamplePercentage
First.Last@gnosis-bio.comJohn.Doe@gnosis-bio.com
98%
Fir.Last@gnosis-bio.comJoh.Doe@gnosis-bio.com
1%
FLast@gnosis-bio.comJDoe@gnosis-bio.com
1%
First.Last@gnosis-us.comJohn.Doe@gnosis-us.com
100%

Frequently Asked Questions

What is Gnosis's phone number?

Minus sign iconPlus sign icon
You can contact Gnosis's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Gnosis's stock symbol?

Minus sign iconPlus sign icon
Gnosis is a publicly traded company; the company's stock symbol is SOND.L.

What is Gnosis's official website and social media links?

Minus sign iconPlus sign icon
Gnosis's official website is gnosis-bio.com and has social profiles on LinkedIn.

What is Gnosis's SIC code NAICS code?

Minus sign iconPlus sign icon
Gnosis's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Gnosis have currently?

Minus sign iconPlus sign icon
As of July 2026, Gnosis has approximately 201 employees across 4 continents, including EuropeNorth AmericaSouth America. Key team members include Quality Unit Director And Qp: G. M.Business Development Director: M. B.Office Manager: C. G. P.. Explore Gnosis's employee directory with LeadIQ.

What industry does Gnosis belong to?

Minus sign iconPlus sign icon
Gnosis operates in the Biotechnology industry.

What technology does Gnosis use?

Minus sign iconPlus sign icon
Gnosis's tech stack includes NameshieldDreamWeaverFont AwesomeLinkedInX-XSS-ProtectionBootstrapX-Content-Type-OptionsApache.

What is Gnosis's email format?

Minus sign iconPlus sign icon
Gnosis's email format typically follows the pattern of First.Last@gnosis-bio.com. Find more Gnosis email formats with LeadIQ.

When was Gnosis founded?

Minus sign iconPlus sign icon
Gnosis was founded in 1989.

Gnosis

BiotechnologyLombardy, Italy201-500 Employees

Gnosis is a Lombardy-based biotechnology company with more than 25 years of experience in manufacturing and selling fermentation raw materials and natural finished products for pharmaceutical, nutraceutical, and veterinary use. It operates an international manufacturing network that emphasizes high-quality, proprietary products and integrates its R&D with GMP-certified facilities to advance production of productive strains and related materials and formulations for human and animal consumption. The company supports health claims for its products through clinical studies conducted in partnership with universities and clinical centers.

The Gnosis Group runs a European manufacturing network with three operating divisions and three commercial operations located in Italy, the USA, and China. In 2017, Gnosis Bio launched Mythocondro, reflecting ongoing development of new products within its portfolio. The organization positions itself within the biotechnology research space by supplying materials and formulations across pharmaceutical, nutraceutical, and veterinary markets.

Section iconCompany Overview

Phone number
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
SOND.L
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
1989
Employees
201-500

Section iconFunding & Financials

  • $1M$10M

    Gnosis's revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $1M$10M

    Gnosis's revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

ยฉ LeadIQ, Inc. All rights reserved.